Kurs
-2,58%
Likviditet
0,01 MSEK
Kalender
| Tid* | ||
| 2025-02-26 | 08:30 | Bokslutskommuniké 2024 |
| 2024-11-26 | - | Kvartalsrapport 2024-Q3 |
| 2024-08-29 | - | Kvartalsrapport 2024-Q2 |
| 2024-05-10 | - | X-dag ordinarie utdelning REDS 0.00 SEK |
| 2024-05-08 | - | Årsstämma |
| 2024-05-08 | - | Kvartalsrapport 2024-Q1 |
| 2024-02-27 | - | Bokslutskommuniké 2023 |
| 2023-11-09 | - | Kvartalsrapport 2023-Q3 |
| 2023-08-29 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-10 | - | X-dag ordinarie utdelning REDS 0.00 SEK |
| 2023-05-09 | - | Årsstämma |
| 2023-05-09 | - | Kvartalsrapport 2023-Q1 |
| 2023-02-27 | - | Bokslutskommuniké 2022 |
| 2022-11-09 | - | Kvartalsrapport 2022-Q3 |
| 2022-08-29 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-03 | - | X-dag ordinarie utdelning REDS 0.00 SEK |
| 2022-05-02 | - | Årsstämma |
| 2022-05-02 | - | Kvartalsrapport 2022-Q1 |
| 2022-02-28 | - | Bokslutskommuniké 2021 |
| 2021-11-09 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-24 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-12 | - | Årsstämma |
| 2021-05-05 | - | X-dag ordinarie utdelning REDS 0.00 SEK |
| 2021-05-03 | - | Kvartalsrapport 2021-Q1 |
| 2021-04-19 | - | Extra Bolagsstämma 2021 |
| 2021-02-28 | - | Bokslutskommuniké 2020 |
| 2020-12-18 | - | Extra Bolagsstämma 2020 |
| 2020-11-09 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-24 | - | Kvartalsrapport 2020-Q2 |
| 2020-06-23 | - | X-dag ordinarie utdelning REDS 0.00 SEK |
| 2020-06-22 | - | Årsstämma |
| 2020-05-04 | - | Kvartalsrapport 2020-Q1 |
| 2020-02-25 | - | Bokslutskommuniké 2019 |
| 2019-11-18 | - | Kvartalsrapport 2019-Q3 |
| 2019-08-26 | - | Kvartalsrapport 2019-Q2 |
| 2019-05-07 | - | X-dag ordinarie utdelning REDS 0.00 SEK |
| 2019-05-06 | - | Årsstämma |
| 2019-05-06 | - | Kvartalsrapport 2019-Q1 |
| 2019-02-26 | - | Bokslutskommuniké 2018 |
| 2018-08-27 | - | Kvartalsrapport 2018-Q2 |
| 2018-05-08 | - | X-dag ordinarie utdelning REDS 0.00 SEK |
| 2018-05-07 | - | Årsstämma |
| 2018-02-27 | - | Bokslutskommuniké 2017 |
| 2017-09-25 | - | Extra Bolagsstämma 2017 |
| 2017-08-28 | - | Kvartalsrapport 2017-Q2 |
| 2017-04-06 | - | X-dag ordinarie utdelning REDS 0.00 SEK |
| 2017-04-05 | - | Årsstämma |
| 2017-02-22 | - | Bokslutskommuniké 2016 |
| 2016-10-26 | - | Kvartalsrapport 2016-Q3 |
| 2016-08-25 | - | Kvartalsrapport 2016-Q2 |
| 2016-05-09 | - | Årsstämma |
| 2016-05-09 | - | Kvartalsrapport 2016-Q1 |
| 2016-02-23 | - | X-dag ordinarie utdelning REDS 0.00 SEK |
| 2016-02-22 | - | Bokslutskommuniké 2015 |
| 2015-11-27 | - | Kvartalsrapport 2015-Q3 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Spotlight |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
A nomination committee has been established ahead of the 2025 annual general meeting in Redsense Medical AB (publ).
The nomination committee, which has been appointed in accordance with the principles adopted by the annual general meeting May 8, 2024, consists of:
Johannes Köpple, appointed by ShapeQ GmbH
Susanne Olauson, appointed by Seventh Sense Adventures Holding AB
Oscar Bergman, appointed by Swedbank Robur Fonder
Susanne Olauson, the chairman of the board is convening
The nomination committee's task is to submit proposals to the annual general meeting regarding; nomination of the chairman at the meeting, number of board members, nomination of the chairman of the board and other members of the board, board fees and, where applicable, remuneration for committee work divided among each member, proposals for the election of auditors and auditors' fees and, to the extent deemed necessary, proposals for changes in current instruction for the Nomination committee.
Shareholders who wish to submit proposals to the nomination committee can do so via e-mail to info@redsensemedical.comno later than January 10, 2025.
The nomination committee's proposal will be presented in the notice to the 2025 annual general meeting and on the company's website; www.redsensemedical.com.
The annual general meeting will be held May 14, 2025, in Halmstad.
For more information, please contact:
Sebastien Bollue, CEO
Telephone: +46 72-171 1264
E-mail: sebastien.bollue (at) redsensemedical.com
Redsense Medical AB (publ), 556646-4862